News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

China Biopharmaceuticals Holdings, Inc. (CHBP.OB) Struggling with Enshi Acquisition



8/16/2007 9:12:24 AM

August 15, 2007 -- China Biopharmaceuticals reported higher revenue and gross profit in its second quarter, though it reported a small loss for the period. The company is continuing to have difficulty with its year-old purchase of Enshi. China Biopharma has sued the former owner and the controlling shareholders of Enshi, seeking redress for what it regards as misrepresentations. On the other hand, the company’s other division, Erye, is performing well. Its revenues were up 31% over the year-ago period. More details...

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES